Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Development and commercialization of the ADAPT® anti-calcification tissue2.7M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States1.78M65.93%
Germany900K33.30%
Australia21K0.78%